KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Capital Expenditures (2016 - 2026)

Pacific Biosciences Of California has reported Capital Expenditures over the past 16 years, most recently at $861000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 46.75% year-over-year to $861000.0; the TTM value through Dec 2025 reached $2.7 million, down 56.14%, while the annual FY2025 figure was $2.7 million, 56.14% down from the prior year.
  • Capital Expenditures for Q4 2025 was $861000.0 at Pacific Biosciences Of California, up from -$86000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $4.9 million in Q4 2022 and troughed at -$787000.0 in Q3 2024.
  • A 5-year average of $2.1 million and a median of $1.6 million in 2024 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: surged 4141.79% in 2021 and later plummeted 194.82% in 2024.
  • Year by year, Capital Expenditures stood at $2.8 million in 2021, then surged by 72.55% to $4.9 million in 2022, then plummeted by 58.73% to $2.0 million in 2023, then dropped by 20.11% to $1.6 million in 2024, then plummeted by 46.75% to $861000.0 in 2025.
  • Business Quant data shows Capital Expenditures for PACB at $861000.0 in Q4 2025, -$86000.0 in Q3 2025, and $550000.0 in Q2 2025.